文献速递精神分裂症与精神病性障碍心境障碍

严重精神障碍中的系统性细胞黏附分子:ICAM-1链接外周与神经炎症的潜在作用

Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation.
PubMed 文献 · Biol Psychiatry · 2022-07-02

该研究在精神分裂症谱系障碍(n=895)、情感障碍(n=737)和健康对照(n=1070)中比较血浆可溶性血管与神经细胞黏附分子水平。主要发现严重精神障碍患者可溶性ICAM-1升高,白细胞ITGB2 mRNA及精神分裂症前额叶ICAM1 mRNA表达增加,且患者诱导多能干细胞衍生神经元释放可溶性ICAM-1增强。结果支持严重精神障碍尤其精神分裂症中存在系统性及脑内可溶性ICAM-1表达失调。

要点

  • 严重精神障碍患者血浆可溶性ICAM-1较健康对照升高。
  • 患者循环白细胞ITGB2 mRNA升高,精神分裂症前额叶ICAM1 mRNA升高。
  • 精神分裂症患者诱导多能干细胞衍生神经元可溶性ICAM-1释放增强。

核心结论

  • 结果支持严重精神障碍尤其精神分裂症中存在系统性和脑内可溶性ICAM-1表达失调。

研究设计与样本

  • 比较精神分裂症谱系障碍(n=895)、情感障碍(n=737)与健康对照(n=1070)的血浆可溶性血管和神经细胞黏附分子水平,并控制年龄、性别、体重指数、C反应蛋白和冻存时间。
  • 利用芯片(n=842)检测白细胞ICAM1及相关受体基因mRNA表达,并在CommonMind Consortium死后背外侧前额叶样本(n=474)中分析RNA测序数据。
  • 在精神分裂症患者与健康对照(各n=8)的诱导多能干细胞衍生神经元和星形胶质细胞中评估可溶性ICAM-1调控。

主要发现

  • 严重精神障碍患者较健康对照血浆可溶性ICAM-1升高。
  • 严重精神障碍患者循环白细胞ITGB2 mRNA升高,精神分裂症患者前额叶ICAM1 mRNA表达升高。
  • 精神分裂症患者诱导多能干细胞衍生神经元可溶性ICAM-1释放增强。

临床怎么用

  • 可关注可溶性ICAM-1作为链接外周与神经炎症的潜在生物标志物,尤其精神分裂症。
  • ICAM-1/ITGB2通路可能为严重精神障碍炎症机制研究提供靶点线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cell adhesion molecules (CAMs) orchestrate leukocyte trafficking and could link peripheral and neuroinflammation in patients with severe mental illness (SMI), by promoting inflammatory and immune-mediated responses and mediating signals across blood-brain barrier. We hypothesized that CAMs would be dysregulated in SMI and evaluated plasma levels of different vascular and neural CAMs. Dysregulated CAMs in plasma were further evaluated in vivo in leukocytes and brain tissue and in vitro in induced pluripotent stem cells. METHODS: We compared plasma soluble levels of different vascular (VCAM-1, ICAM-1, P-SEL) and neural (JAM-A, NCAD) CAMs in circulating leukocytes in a large SMI sample of schizophrenia (SCZ) spectrum disorder (n = 895) and affective disorder (n = 737) and healthy control participants (n = 1070) controlling for age, sex, body mass index, C-reactive protein, and freezer storage time. We also evaluated messenger RNA expression of ICAM1 and related genes encoding ICAM-1 receptors in leukocytes using microarray (n = 842) and in available RNA sequencing data from the CommonMind Consortium (CMC) in postmortem samples from the dorsolateral prefrontal cortex (n = 474). The regulation of soluble ICAM-1 in induced pluripotent stem cell-derived neurons and astrocytes was assessed in patients with SCZ and healthy control participants (n = 8 of each). RESULTS: Our major findings were 1) increased soluble ICAM-1 in patients with SMI compared with healthy control participants; 2) increased ITGB2 messenger RNA, encoding the beta chain of the ICAM-1 receptor, in circulating leukocytes from patients with SMI and increased prefrontal cortex messenger RNA expression of ICAM1 in SCZ; and 3) enhanced soluble ICAM-1 release in induced pluripotent stem cell-derived neurons from patients with SCZ. CONCLUSIONS: Our results support a systemic and cerebral dysregulation of soluble ICAM-1 expression in SMI and especially in patients with SCZ.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Sheikh MA, O'Connell KS, Lekva T, et al. Systemic Cell Adhesion Molecules in Severe Mental Illness: Potential Role of Intercellular CAM-1 in Linking Peripheral and Neuroinflammation. Biol Psychiatry. 2022. PMID: 36182530. doi:10.1016/j.biopsych.2022.06.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。